Id |
Subject |
Object |
Predicate |
Lexical cue |
T73 |
0-215 |
Sentence |
denotes |
Like SARS-CoV and MERS-CoV, SARS-CoV-2 also originates from bats.22–24 Next, we detected the binding affinity of the identified SARS-CoV-2 RBD to bat ACE2 (bACE2) and compared this binding with that of SARS-CoV RBD. |
T74 |
216-399 |
Sentence |
denotes |
We transiently transfected a bACE2-expressing plasmid into 293T cells and included a hACE2-expressing plasmid as a control, followed by detection of fluorescence intensity 48 h later. |
T75 |
400-632 |
Sentence |
denotes |
Results indicated that SARS-CoV-2 RBD bound strongly to 293T-expressed bACE2 with intensity similar to that of its binding to 293T-expressed hACE2 (Fig. 3a, c), and that this binding occurred in a dose-dependent manner (Fig. 3e, f). |
T76 |
633-721 |
Sentence |
denotes |
In addition, the binding affinity between SARS-CoV-2 RBD and 293T-expressed bACE2 (EC50: |
T77 |
722-749 |
Sentence |
denotes |
0.08 μg/ml) or hACE2 (EC50: |
T78 |
750-849 |
Sentence |
denotes |
0.14 μg/ml) was significantly higher than that between SARS-CoV RBD and 293T-expressed bACE2 (EC50: |
T79 |
850-877 |
Sentence |
denotes |
0.96 μg/ml) or hACE2 (EC50: |
T80 |
878-905 |
Sentence |
denotes |
1.32 μg/ml) (Fig. 3b, d–f). |
T81 |
906-995 |
Sentence |
denotes |
Nevertheless, MERS-CoV RBD bound neither bACE2- nor hACE2-expressing 293T cells (Fig. 3). |
T82 |
996-1196 |
Sentence |
denotes |
These data suggest that SARS-CoV-2 RBD can bind to both bACE2 and hACE2 with significantly stronger binding than that of SARS-CoV RBD to either bACE2 or hACE2, supporting the bat origin of SARS-CoV-2. |
T83 |
1197-1284 |
Sentence |
denotes |
These results may partially explain why SARS-CoV-2 is more transmissible than SARS-CoV. |
T84 |
1285-1369 |
Sentence |
denotes |
Fig. 3 Comparison of SARS-CoV-2 RBD protein binding to human and bat ACE2 receptors. |
T85 |
1370-1512 |
Sentence |
denotes |
Flow cytometry analysis of SARS-CoV-2 RBD binding to hACE2 and bat ACE2 (bACE2) receptors in 293T cells transiently expressing hACE2 or bACE2. |
T86 |
1513-1662 |
Sentence |
denotes |
293T cells were transiently transfected with hACE2 or bACE2 plasmid and incubated with SARS-CoV-2 RBD protein at various concentrations for analysis. |
T87 |
1663-1724 |
Sentence |
denotes |
SARS-CoV RBD and MERS-CoV RBD proteins were used as controls. |
T88 |
1725-1872 |
Sentence |
denotes |
Representative images of SARS-CoV-2 RBD protein (2.5 μg/ml) binding to bACE2/293T (a, black line), or hACE2/293T (c, black line), cells were shown. |
T89 |
1873-2007 |
Sentence |
denotes |
Binding of SARS-CoV RBD protein (2.5 μg/ml) to bACE2/293T (b, red line), or hACE2/293T (d, red line), cells were used as a comparison. |
T90 |
2008-2240 |
Sentence |
denotes |
MERS-CoV RBD protein (green line) and mock-incubated (gray shading) cells (a–d) were included as controls. e, f Dose-dependent binding of SARS-CoV-2 RBD protein to bACE2/293T (e), or hACE2/293T (f), cells by flow cytometry analysis. |
T91 |
2241-2432 |
Sentence |
denotes |
Significant differences between binding of SARS-CoV-2 RBD (black) and SARS-CoV RBD (red) to cell-associated bACE2 receptor (e), or hACE2 receptor (f) were identified based on the EC50 values. |
T92 |
2433-2481 |
Sentence |
denotes |
The data are presented as mean ± s.e.m. (n = 4). |
T93 |
2482-2541 |
Sentence |
denotes |
Experiments were repeated twice and yielded similar results |